Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
7 participants
INTERVENTIONAL
2023-02-28
2023-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Changing Health Behaviors to Manage Chronic Conditions in Community-dwelling African American Breast Cancer Survivors
NCT03575624
Peer Navigator Education in Improving Survivorship Care in African American Breast Cancer Survivors
NCT01450020
Health Education for Women With Breast Cancer
NCT05873296
Survivor Stories: Impact on Cancer Patients' Quality of Life and Follow-up
NCT00929084
A Post-treatment Supportive Service Program for the Transition Into Survivorship for Black Women Breast Cancer Survivors in Western New York
NCT06833255
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
SUPPORTIVE_CARE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Breast Cancer Survivor Education Program
Participants will complete study procedures as outlined:
\- 6 weekly sessions of a modified version of the PAVING the Path to Wellness education program.
Breast Cancer Survivor Education Program
Weekly sessions via Zoom platform with study staff.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Breast Cancer Survivor Education Program
Weekly sessions via Zoom platform with study staff.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Self-identified Black or African American race
* Age 22-79
* Diagnosis of Stage I, II, or III invasive breast cancer
* Completed active treatment at least 6 months ago, but within the past five years
* Speaks English
Exclusion Criteria
* Undergoing evaluation for suspected recurrence
22 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
American Cancer Society, Inc.
OTHER
Pfizer
INDUSTRY
Massachusetts General Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Erica T. Warner, ScD MPH
Principal Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Erica Warner, MPH, ScD
Role: PRINCIPAL_INVESTIGATOR
Massachusetts General Hospital
Amy Comander, MD
Role: STUDY_DIRECTOR
Massachusetts General Hospital
Naomi Ko, MD
Role: STUDY_DIRECTOR
Boston Medical Center
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Massachusetts General Hospital Cancer Center
Boston, Massachusetts, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
22-509
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.